LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
AI business accelerates but revenue inflection point still needs confirmation. Wall Street holds a cautious but optimistic outlook on Salesforce, Inc. (CRM.US).
US Stock Market Move | Popular Chinese concept stocks mostly fell. KE Holdings, Inc. Sponsored ADR Class A (BEKE.US) fell by nearly 6%.
US Stock Market Move | NVIDIA Corporation (NVDA.US) responded to investors' bearish views after its performance report, causing a drop of over 5% in early trading.
AI business accelerates but revenue inflection point still needs confirmation. Wall Street holds a cautious but optimistic outlook on Salesforce, Inc. (CRM.US).
US Stock Market Move | Popular Chinese concept stocks mostly fell. KE Holdings, Inc. Sponsored ADR Class A (BEKE.US) fell by nearly 6%.
US Stock Market Move | NVIDIA Corporation (NVDA.US) responded to investors' bearish views after its performance report, causing a drop of over 5% in early trading.
RECOMMEND
Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026
Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026
AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026
